Monday, August 31, 2026

Trump and Kim Min-seok’s Unexpected 20-Minute Meeting: What It Means for North Korea Relations

Prime Minister Kim Min-seok's meeting with Trump focused on North Korea relations and U.S.-Korea cooperation, emphasizing open dialogue.

Discover the Legacy: Hanmi Group Unveils Monument Honoring Founder Lim Seong-ki

Hanmi Group honors founder Lim Seong-ki with a bronze sculpture, celebrating his legacy in pharmaceutical innovation and drug development.

North Korea Likely Sold Weapons to Hamas

The U.S. think tank, Center for Strategic...

Tag: analysis

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Revolutionizing Cardiovascular Care: How Quantum Computing is Transforming Blood Flow Analysis in 2026

Seoul St. Mary's Hospital develops technology using quantum computing to analyze blood flow in cardiovascular patients quickly and precisely.

Celltrion Publishes Population Pharmacokinetic Analysis of Vegzelma in International Journal

Celltrion has published integrated population pharmacokinetic analysis results for its Avastin biosimilar Vegzelma, confirming pharmacokinetic similarity with the reference drug.

AI in Alzheimer’s Care: JLK’s TRACEGENT-AD Secures Medical Device Certification

JLK has secured domestic certification for its AI medical device analyzing MRI signals for Alzheimer's disease abnormalities.

Revolutionizing Stroke Treatment: JLK’s AI Solution in 22 Hospitals

JLK, a medical AI firm, initiates a large-scale clinical study on stroke AI imaging solutions across 22 hospitals in Korea.

AriBio Completes Global Phase 3 Trial of Alzheimer’s Drug AR1001, Awaits Topline Results

AriBio completes final patient follow-up in Phase 3 trial for Alzheimer's treatment AR1001, entering data analysis phase.

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Lunit Joins Global AI Consortium for Next-Gen Drug Development: What This Means for Precision Medicine

Lunit joins an AI consortium to enhance drug development through AI-driven pathology and biomarker analysis, collaborating with global firms.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.